[1]
“Advancing BTK Inhibition: Non‑Covalent Bruton Tyrosine Kinase Inhibitors and Their Emerging Role in Canadian Practice”, Can Hematol Today, vol. 4, no. s04, pp. 2–15, Jun. 2025, doi: 10.58931/cht.2025.4s0469.